Ledger.Open graph →
SEC Form D · Amendment · filed April 24, 2019

Bridge Therapeutics, Inc

Offering
—
Sold
$2.0M
Exemption
Rule 506(c)
Industry
Pharmaceuticals
Location
BIRMINGHAM, AL
Type
—

Rule 506(c): private placement that may advertise publicly; all investors must be verified accredited.

People & firms on this filing (16)

Joseph S. Mullin · Birmingham, ALDirectorDavid H. Bergstrom · Birmingham, ALDirectorElizabeth G. Kelley · Birmingham, ALDirectorJames G. Sullivan · Birmingham, ALExec · DirectorDiana H. Harshbarger · Birmingham, ALDirectorKelley S. Alton · Birmingham, ALExec · DirectorTim G. Peara · Birmingham, ALExecRussell G. Kelley · Birmingham, ALPromoterJoseph S. Mullin · Birmingham, ALDirectorDavid H. Bergstrom · Birmingham, ALDirectorElizabeth G. Kelley · Birmingham, ALDirectorTim G. Peara · Birmingham, ALExecJames G. Sullivan · Birmingham, ALExec · DirectorRussell G. Kelley · Birmingham, ALPromoterDiana H. Harshbarger · Birmingham, ALDirectorKelley S. Alton · Birmingham, ALExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗